Outcomes and Predictors of In-hospital Mortality in Nonagenarians with NSTEMI: A Comparison of PCI and Medical Management

Nonagenarians, the fastest-growing U.S. age group, face a high burden of Non-ST-Elevation Myocardial Infarction (NSTEMI), yet the utilization and outcomes of percutaneous coronary intervention (PCI) in this population remain poorly understood. The aims of this study were to assess patient characteristics, comorbidities, and in-hospital outcomes in nonagenarians and identify predictors of in-hospital mortality. We analyzed 122,845 hospitalizations with a principal discharge diagnosis of NSTEMI among nonagenarians using the National Inpatient Sample (2015-2019) to compare PCI (8%) versus medical management (92%). Over the study period, there was an 18% reduction in medically managed cases (p = 0.04), while PCI utilization increased from 7% to 9% (p = 0.03). The medical management cohort had significantly higher Elixhauser comorbidity (EC) scores (p <0.001), 30-day readmission EC scores (p <0.001), in-hospital mortality EC scores (p <0.001), and in-hospital mortality rate (7.9% vs 4.2%; p <0.001). Mortality predictors differed: mortality in the medical management group was most strongly associated with alcohol abuse, chronic blood loss anemia, and diabetes; whereas mortality in the PCI group correlated most strongly with inotrope/vasopressor use, chronic pulmonary disease, prior transient ischemic attack, and peripheral vascular disease. Despite rising adoption, PCI remains underutilized in nonagenarians. PCI is linked to lower in-hospital mortality. The distinct comorbidity profiles and mortality predictors underscore the need for individualized treatment strategies in this vulnerable elderly population.

Key Question

  • How do clinical outcomes, including in-hospital mortality, compare in nonagenarian patients with NSTEMI treated with percutaneous coronary intervention (PCI) versus medical management?

  • What are the key predictors of in-hospital mortality in each cohort?

Clinical Perspectives

  • 1)

    Despite the potential benefits of PCI, it remains significantly underutilized in nonagenarians hospitalized with NSTEMI, with only 8% receiving it between 2015 and 2019.

  • 2)

    PCI use was associated with significantly lower in-hospital mortality (4.2%) compared to medical management (7.9%), reinforcing the need for its broader application in nonagenarians admitted with NSTEMI.

  • 3)

    Key predictors of in-hospital mortality varied between the cohorts. For PCI patients, inotrope/vasopressor use, chronic pulmonary disease, prior transient ischemic attack, and peripheral vascular disease were associated with significantly increased odds of in-hospital mortality; whereas alcohol abuse, diabetes, and chronic blood loss anemia were the strongest predictors in the medically managed group.

  • 4)

    PCI was associated with a higher hospitalization cost ($108,812) compared to medical management ($42,858), but the improved outcomes and lower mortality suggest its value in reducing long-term healthcare burdens.

  • 5)

    The PCI cohort exhibited lower Elixhauser comorbidity scores, suggesting that comorbidities heavily influence outcomes, and careful selection of treatment approaches based on comorbidity profiles could improve patient prognosis.

Nonagenarians represent the fastest-growing segment in the U.S. population. According to a report by the U.S. Census Bureau and supported by the National Institute on Aging, the nation’s 90-and-older population nearly tripled over the past 3 decades, reaching 1.9 million in 2010 ,, and is projected to quadruple in the next 4 decades.

Acute myocardial infarction (AMI) remains a leading cause of mortality in nonagenarians. ,, Non-ST-Elevation Myocardial Infarction (NSTEMI) represents a significant burden on both patients and healthcare systems. Current guidelines recommend percutaneous coronary intervention (PCI) as the preferred treatment strategy for type 1 NSTEMI. ,, However, despite prior studies showing the efficacy of PCI in nonagenarians with NSTEMI, there is consistent underutilization of PCI in this cohort. This could be due to concerns for perceived procedural risks in this age group and limited inclusion of nonagenarians in large randomized controlled studies. ,, However, chronological age alone should not dictate therapy decisions; rather, factors such as frailty, functional and cognitive status, and comorbidities are critical determinants of outcomes in this population. Current evidence regarding temporal trends in treatment patterns and associated clinical outcomes for NSTEMI in nonagenarians remains limited. Particularly, data examining predictors of in-hospital mortality in this vulnerable population is scarce. Our study therefore aims to address this knowledge gap by evaluating: (1) temporal trends in NSTEMI management strategies (medical management vs PCI) in nonagenarian patients and (2) comparative outcomes between the 2 groups.

Methods

Data source

The study cohort was obtained from the National Inpatient Sample (NIS) database, sponsored by the Agency for Healthcare Research and Quality (AHRQ) as part of the Healthcare Cost and Utilization Project (HCUP). The primary goal of the NIS is to produce nationally representative estimates of healthcare resource utilization, access, quality, and outcomes in the United States (US). It stands as the largest healthcare database in the US, encompassing deidentified discharge data from over 7 million hospitalizations annually. This extensive data set covers approximately 20% of all inpatient hospital stays across all regions of the country. By consolidating the collected data, a comprehensive national database is created, facilitating retrospective research analyses.

Study population

This study included all adult hospitalizations (age ≥90 years) with an NSTEMI diagnosis from January 2015 to December 2019. The study sample was identified based on the principal discharge diagnosis of NSTEMI, using the International Classification of Diseases, 10th revision (ICD-10) clinical modification (CM) code I21.4 and ICD-9-CM codes 410.7 and 410.9. We excluded hospitalizations for patients who died on the day of admission to ensure that only patients with the opportunity to receive in-hospital evaluation and treatment were included. In addition, patients with a diagnosis of acute gastrointestinal hemorrhage (ICD-10-CM: K92.2, ICD-9-CM: 578.9) during the index hospitalization were excluded to minimize confounding from acute bleeding events that could influence both treatment selection and clinical outcomes. Within this cohort, we further categorized patients into 2 groups: those treated with PCI and those receiving medical management. PCI treatment was identified using ICD-10 procedure coding system (PCS) codes (0270346, 027034Z, 02703D6, 02703DZ, 02703Z6, 02703ZZ, 0270446, 027044Z, 02704D6, 02704DZ, 02704Z6, 02704ZZ), and ICD-9-CM procedure codes (00.66, 36.01, 36.02, 36.05, 36.06, 36.07) documented during the same hospitalization. Patients who underwent left heart catheterization (LHC) or coronary angiogram (CAG) but did not subsequently undergo PCI were included in the medical management cohort.

Predictors

We summarized factors that can potentially differentiate between the 2 cohorts and categorized them into (1) patient characteristics (age, gender, patient location, household income, primary payer), (2) admission features (mortality risk, severity, admission day, month, length of stay, disposition, ED service, number of diagnosis/procedures, total charge), (3) comorbidities and Elixhauser comorbidity-associated risk scores and (4) procedures. The complexity of comorbid conditions was measured using the Elixhauser Comorbidity (EC) score, calculated by summing the 29 individual comorbidities. , These comorbidities were identified from International Classification of Diseases (ICD-9-CM and ICD-10-CM) administrative coding within the NIS database. 30-Day Readmissions EC (REC) and In-hospital Mortality EC (MEC) risk scores were calculated using the weights proposed by Moore et al. ,, These EC, REC, and MEC risk scores were used to quantify the comprehensive comorbidity burdens and to evaluate their association with in-hospital mortality. Through this analysis, we aimed to differentiate and compare the characteristics and comorbidity profiles of the 2 cohorts. This information is crucial for understanding the complexity of the comorbidities and their impact on in-hospital mortality.

Goal

The objective of this study was to investigate the prevalence and temporal trends of hospitalizations for NSTEMI while examining patient characteristics, admission features, comorbidities, and procedures among patients who received either medical management or PCI from 2015 to 2019. In addition, we sought to assess all-cause in-hospital mortality rates, stratified by the presence of PCI, and identify predictors of in-hospital mortality within the elderly cohorts with primary NSTEMI. Through this comprehensive analysis, our goal was to improve understanding of the relationship between NSTEMI, PCI treatment, and inpatient mortality. Furthermore, we aimed to elucidate the prognostic factors contributing to mortality in nonagenarian patients admitted with primary NSTEMI, thereby providing valuable insights for clinical management and patient care in this population.

Statistical analysis

All analyses incorporated discharge-level weights, strata, and hospital clustering provided in the NIS data from AHRQ to account for variation in sampling. Age-adjusted hospitalization and in-hospital mortality rates were calculated for each year using direct methods for adjustment based on the age distribution of the United States population in the year 2020.

Temporal trends were assessed using the 2-tailed Mann–Kendall test. Descriptive summary statistics for baseline characteristics were presented as frequencies with percentages for categorical variables. Groups undergoing PCI compared to medical management were compared using Pearson’s χ² test. Summary statistics for continuous variables were reported as means with standard deviation (SD) for normally distributed continuous variables, and medians with interquartile ranges (IQR) for non-normally distributed continuous data. Wilcoxon rank-sum tests were used to compare baseline characteristics between groups who undergo PCI or medical management.

Weighted multivariate logistic regressions were used to assess the predictors of in-hospital mortality. Covariates included patient comorbidity (Elixhauser Comorbidity Index), and clinically relevant variables reflecting disease severity or management (e.g., inotrope/vasopressor use, mechanical ventilation) that were clinically relevant and demonstrated statistical significance, after adjusting for sex and race. Multicollinearity was evaluated using the Variance Inflation Factor (VIF), with a cutoff of >5 considered indicative of high collinearity. No covariates exceeded this threshold. Models were implemented using the PROC SURVEYLOGISTIC procedure in SAS 9.4 (SAS Institute Inc., Cary, NC), which accounts for stratification, clustering, and weighting in variance estimation. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC). All p Values were assessed using a 2-sided approach, with statistical significance set at an alpha level of 0.05.

Results

There were approximately 126,895 NSTEMI hospitalizations for elderly patients aged 90 and above between 2015 and 2019. After excluding hospitalizations for patients who died on the day of admission ( n = 3,245) and patients who experienced gastrointestinal hemorrhage ( n = 4,865), we identified 122,845 hospitalizations. Out of these patients, 9,700 (8%) received PCI treatment, while 113,145 (92%) underwent medical management ( Figure 1 ). In the medical management cohort, 14.3% of patients underwent LHC/CAG but not subsequent PCI. This subgroup likely consisted of patients who had nonobstructive CAD that was not amenable to PCI or had CAD that was too anatomically complex or high risk to be subjected to PCI.

Figure 1

NSTEMI hospitalizations from 2015 to 2019 that included medical management or PCI.

Between 2015 and 2019, a significant decline of 17% (p = 0.04) was observed in the annual admissions per 1,000 individuals. Similarly, the admission rate for patients undergoing medical management also showed a significant 18% decline (p = 0.04), dropping from 9.5 per 1,000 hospitalizations in 2015 to 7.9 per 1,000 hospitalizations in 2019. In contrast, there was no discernible temporal pattern in the admission rate for patients undergoing PCI (p = 0.71) ( Figure 2 ).

Figure 2

Temporal trends in NSTEMI hospitalizations per 1,000 US adults aged ≥ 90 years.

In the PCI group, women comprised 49.8% of the cohort, whereas they constituted 61% in the medical management group. Hospitalizations involving PCI were associated with a higher proportion of white patients (84.8% vs 82.6%; p <0.001), lower mortality risk (9% vs 50%; p <0.001), reduced disease severity (44% vs 50%; p <0.001), more weekday admissions (76% vs 73%; p = 0.01), more admissions via the emergency department (ED) (29% vs 17%; p <0.001), and more discharges to home or self-care (47% vs 27%; p <0.001) compared to hospitalizations involving medical management ( Table 1 ).

Table 1

Baseline patient characteristics and admission features of NSTEMI patients stratified by PCI

Medical management PCI p value
Unweighted admission 22,630 (92%) 1,940 (8%)
Weighted admission 113,145 (92%) 9,700 (8%)
Patient characteristics (%)
Gender <0.001
Male 39.46 50.18
Female 60.54 49.82
Race <0.001
White 82.60 84.80
Black 6.79 4.75
Hispanic 5.69 5.22
Asian or Pacific Islander 2.55 2.21
Native American 0.18 0.06
Patient location 0.996
Metropolitan (≥1M) 54.57 54.56
Metropolitan (<1M) 29.52 29.47
Micropolitan 9.17 9.25
Others 6.75 6.72
Median household income <0.001
1st Quarter 25.56 22.24
2nd Quarter 27.20 27.94
3rd Quarter 24.57 26.49
4th Quarter 22.68 23.33
Primary payer 0.08
Medicare 51.28 51.09
Medicaid 18.46 17.53
Private insurance 24.41 25.37
Self-Pay 5.85 6.01
Admission feature
Mortality risk <0.001
Minor likelihood of dying 0.67 15.07
Moderate likelihood of dying 8.61 35.41
Major likelihood of dying 70.72 33.17
Extreme likelihood of dying 20.00 16.34
Severity <0.001
Minor loss of function 8.04 0.61
Moderate loss of function 35.68 54.84
Major loss of function 38.57 29.84
Extreme loss of function 17.71 14.71
Admission days 0.01
Weekdays 72.97 76.15
Weekend 27.03 23.85
Admission month 0.587
January-March 25.67 26.94
April-June 22.65 21.49
July-September 22.02 22.22
October-November 29.66 29.36
Length of stay (Average ± STD ) 4.2 ± 0.06 4.7 ± 0.22 <0.001
Disposition <0.001
Home or self-care 26.66 47.34
Transfer to other healthcare facilities 39.97 24.88
Home healthcare 25.02 23.31
Against medical advice 7.92 4.24
Total charge (Average ± STD ; $) 42,858 ± 4,158 108,812 ± 7197 <0.001
Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Aug 8, 2026 | Posted by in CARDIOLOGY | Comments Off on Outcomes and Predictors of In-hospital Mortality in Nonagenarians with NSTEMI: A Comparison of PCI and Medical Management

Full access? Get Clinical Tree

Get Clinical Tree app for offline access